In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: DaVita Inc. trades 12.3% above its weighted fair value of $201.51, indicating potential overvaluation given mixed valuation methods with high confidence in DCF and analyst targets. Financial health is moderate, with profitability at zero and high leverage, signaling risk. Monte Carlo analysis shows high volatility and downside risk at 33.3%, implying uncertain valuation outcomes.